Literature DB >> 11807726

Levels of chloroquine resistance in Plasmodium falciparum are determined by loci other than pfcrt and pfmdr1.

Nanhua Chen, Bruce Russell, Elizabeth Fowler, Jennifer Peters, Qin Cheng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11807726     DOI： 10.1086/338470

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  17 in total

1.  pfcrt Allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines.

Authors:  Nanhua Chen; Dennis E Kyle; Cielo Pasay; Elizabeth V Fowler; Joanne Baker; Jennifer M Peters; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

2.  Degrees of chloroquine resistance in Plasmodium - is the redox system involved?

Authors:  Adele M Lehane; Christopher A McDevitt; Kiaran Kirk; David A Fidock
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-12-01       Impact factor: 4.077

3.  Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum.

Authors:  Rajeev K Mehlotra; Gabriel Mattera; Moses J Bockarie; Jason D Maguire; J Kevin Baird; Yagya D Sharma; Michael Alifrangis; Grant Dorsey; Philip J Rosenthal; David J Fryauff; James W Kazura; Mark Stoneking; Peter A Zimmerman
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

4.  Differential drug efflux or accumulation does not explain variation in the chloroquine response of Plasmodium falciparum strains expressing the same isoform of mutant PfCRT.

Authors:  Adele M Lehane; Donelly A van Schalkwyk; Stephanie G Valderramos; David A Fidock; Kiaran Kirk
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

5.  Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan.

Authors:  Michela Menegon; Albadawi A Talha; Carlo Severini; Sayed M Elbushra; Ahmed A Mohamedani; Elfatih M Malik; Tarig A Mohamed; Walther H Wernsdorfer; Giancarlo Majori; Bakri Y M Nour
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

6.  Physical linkage to drug resistance genes results in conservation of var genes among West Pacific Plasmodium falciparum isolates.

Authors:  Elizabeth V Fowler; Marina Chavchich; Nanhua Chen; Jennifer M Peters; Dennis E Kyle; Michelle L Gatton; Qin Cheng
Journal:  J Infect Dis       Date:  2006-08-23       Impact factor: 5.226

7.  A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance.

Authors:  Viswanathan Lakshmanan; Patrick G Bray; Dominik Verdier-Pinard; David J Johnson; Paul Horrocks; Rebecca A Muhle; George E Alakpa; Ruth H Hughes; Steve A Ward; Donald J Krogstad; Amar Bir Singh Sidhu; David A Fidock
Journal:  EMBO J       Date:  2005-06-09       Impact factor: 11.598

8.  Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross.

Authors:  Jigar J Patel; Drew Thacker; John C Tan; Perri Pleeter; Lisa Checkley; Joseph M Gonzales; Bingbing Deng; Paul D Roepe; Roland A Cooper; Michael T Ferdig
Journal:  Mol Microbiol       Date:  2010-09-29       Impact factor: 3.501

9.  Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum.

Authors:  Stephanie G Valderramos; Juan-Carlos Valderramos; Lise Musset; Lisa A Purcell; Odile Mercereau-Puijalon; Eric Legrand; David A Fidock
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

10.  The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.

Authors:  Fredrick L Eyase; Hoseah M Akala; Luiser Ingasia; Agnes Cheruiyot; Angela Omondi; Charles Okudo; Dennis Juma; Redemptah Yeda; Ben Andagalu; Elizabeth Wanja; Edwin Kamau; David Schnabel; Wallace Bulimo; Norman C Waters; Douglas S Walsh; Jacob D Johnson
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.